Development of pet imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
Ended Project Grant Awarded Last action
- Award ID
- R01CA204723
- Recipient
-
Omniox Inc. UEI MERZH84KMHM6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,738,721
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$57,753 | |
| Amendment | $522,676 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $538,027 | |
| Amendment | $704 | |
| Amendment | $0 | |
| Amendment | $546,766 | |
| Amendment | $585,583 | |
| Original award | $602,718 |
Quick answers
Who received award R01CA204723?
R01CA204723 was awarded to Omniox Inc. by National Cancer Institute (National Institutes of Health) on April 27, 2017.
How much is award R01CA204723 worth?
$2,738,721 has been obligated on R01CA204723.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award